iBio Inc. Stock
For the coming years our community has positive and negative things to say abot the iBio Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
iBio is a listed biotechnology company with the ticker symbol iBio that focuses on developing novel plant-based biologics and vaccines to combat infectious diseases and other medical conditions. The company leverages its proprietary expression technology to rapidly produce high-quality proteins at a commercial scale, providing a cost-effective and scalable alternative to traditional manufacturing processes. iBio has strategic collaborations with leading pharmaceutical companies and is actively exploring partnerships to advance its product pipeline and expand its reach. The company is headquartered in Bryan, Texas, and is publicly traded on the NYSE American stock exchange.
Pros and Cons of iBio Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of iBio Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| iBio Inc. | - | - | - | - | - | - | - |
| Biotec Pharmacon ASA | -1.170% | -2.759% | -12.963% | -31.664% | -41.250% | -80.755% | 400.000% |
| PharmAust Ltd. | 2.880% | -21.898% | -50.000% | 114.000% | 73.984% | 87.719% | 568.750% |
| Vaxart Inc. | -5.240% | 9.535% | -41.053% | -15.301% | 30.334% | -89.873% | - |
Comments
iBio, Inc. (NYSE: IBIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for IBIO provided by MarketBeat
iBio, Inc. (NYSE: IBIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for IBIO provided by MarketBeat
